当前位置: X-MOL首页SCI期刊查询及投稿分析系统 › Expert Review of Molecular Diagnostics杂志
Expert Review of Molecular Diagnostics
基本信息
期刊名称 Expert Review of Molecular Diagnostics
EXPERT REV MOL DIAGN
期刊ISSN 1473-7159
期刊官方网站 https://www.tandfonline.com/journals/iero20
是否OA No
出版商 Taylor and Francis Ltd.
出版周期 Bimonthly
文章处理费 登录后查看
始发年份 2001
年文章数 106
影响因子 3.9(2023)  scijournal影响因子  greensci影响因子
中科院SCI期刊分区
大类学科 小类学科 Top 综述
医学3区 PATHOLOGY 病理学3区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 6.6 0.823 0.770
Medicine
Pathology and Forensic Medicine
35/208 83%
Biochemistry, Genetics and Molecular Biology
Genetics
113/347 67%
Biochemistry, Genetics and Molecular Biology
Molecular Medicine
77/178 57%
Biochemistry, Genetics and Molecular Biology
Molecular Biology
186/410 54%
补充信息
自引率 1.80%
H-index 68
SCI收录状况 Science Citation Index Expanded
官方审稿时间 登录后查看
网友分享审稿时间 数据统计中,敬请期待。
接受率 登录后查看
PubMed Central (PMC) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1473-7159%5BISSN%5D
投稿指南
期刊投稿网址 https://mc.manuscriptcentral.com/ero
收稿范围
Expert Review of Molecular Diagnostics [ISSN 1473-7159]; [e-ISSN 1744-8352] is a MEDLINE-indexed, international subscription-based journal publishing rigorously peer-reviewed review articles and original papers in molecular diagnostics. The journal covers the detection and monitoring of the molecular causes of disease that are being translated into ground-breaking diagnostic and prognostic technologies to be used in the clinical diagnostic setting.

Expert Review of Molecular Diagnostics provides a forum for reporting the critical advances being made in this ever-expanding field, as well as the major challenges ahead in their clinical implementation. The journal delivers this information in concise, at-a-glance article formats: invaluable to a time-constrained community.

Articles focus on the following key areas:

    Contemporary genetic and genomic technologies including deep sequencing and genome-wide association studies.
    Molecular tools for infectious disease testing and detection of multiple resistant bacteria.
    Latest discoveries in oncology diagnostics.
    Progress in non-invasive prenatal testing, including molecular markers and ethical considerations.
    'Omic’ diagnostic technologies including: pharmacogenomic, epigenomic, proteomic and metabolomic technologies.
    Disease predisposition and inherited genetic diseases testing.
    Diagnostic tests for point-of-care settings and for resource-limited settings as well as progress in developing handheld devices for molecular diagnostic tests.
    Progress in developing handheld devices for molecular diagnostic tests.
    Biomarker development and usage to target patient groups for personalized medicine.
    Tools for molecular prognosis.
    Novel technologies and developments in molecular diagnostic techniques.
    Regulatory, ethical and payor perspectives in molecular diagnostics.

Each issue of Expert Review of Molecular Diagnostics contains:

    Reviews on current and emerging topics relating to molecular diagnostics.
    Editorials discussing contentious issues in the field.
    Diagnostic profiles featuring independent, expert evaluations of diagnostic tests.
    Original Research - manuscripts detailing clinical studies with a presentation of previously unpublished data.

Comprehensive coverage in each review is complemented by the unique Expert Collection format and includes the following sections:

Expert Opinion – a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results;

Article Highlights – an executive summary of the author’s most critical points.

Once your paper has been assessed for suitability by the Editorial Team, it will then be double-anonymous peer-reviewed by independent, expert referees.

Reach an international clinical and medical audience alongside other key option leaders in your field by publishing with Expert Review of Molecular Diagnostics, part of the Expert Collection brand.
收录体裁
投稿指南 https://www.tandfonline.com/action/authorSubmission?show=instructions&journalCode=iero20
投稿模板
参考文献格式
编辑信息

Editor-in-Chief

Attila T Lorincz, Queen Mary University of London, UK 


Associate Editors
 

William C S Cho, Queen Elizabeth Hospital, Hong Kong 

Samir Hanash, Fred Hutchinson Cancer Research Center, WA, USA 

Tim Harris, Biogen Idec, MA, USA 

George Poste, Arizona State University, AZ, USA 

Jeffrey S Ross, Albany Medical College, NY, USA


Editorial Board Members

Blair E, Integrated Medicines Ltd, Cambridge, UK

Borrebaeck C, Lund University, Lund, Sweden

Borry P, Katholieke Universiteit Leuven, Leuven, Belgium

Calin GA, University of Texas: MD Anderson Cancer Center, TX, USA

Cantor CR, Agena Bioscience, San Diego, CA, USA

Hardiman G, Medical University of South Carolina, SC, USA

Ichiishi E, International University of Health and Welfare Hospital, Nasushiobara City, Japan

Jiang S-W, Mercer University, GA, USA

Kelley SO, University of Toronto, Toronto, Canada

Klein R, Cleveland Clinic, OH, USA

Liotta LA, George Mason University, VA, USA

Ogino S, Dana-Farber Cancer Institute, MA, USA

Pai M, McGill University, Montreal, Canada

Pritzker KH, RNA Diagnostics Inc., Toronto, Canada

Salto-Tellez M, Queen’s University Belfast, Belfast, UK

Povoski SP, Ohio State University, OH, USA

Wojdacz TK, University of Aarhus, Aarhus, Denmark

Trøst Jørgensen J, Dx-Rx Institute, Fredensborg, Denmark 

Pai N, McGill University, Montreal, Canada 

Van Der Pol B, University of Alabama at Birmingham School of Medicine, AL, USA 

Rolain JM, Aix-Marseille Université, Marseille, France 

Franciotta D, C. Mondino National Neurological Institute, Pavia, Italy 

McCarthy MW, Cornell University, NY, USA 

Chan KCA, The Chinese University of Hong Kong, Hong Kong SAR, China 

Schittenhelm J, Eberhard Karls University Tuebingen, Tuebingen, Germany 


我要分享  (欢迎您来完善期刊的资料,分享您的实际投稿经验)
研究领域:
投稿录用情况: 审稿时间:  个月返回审稿结果
本次投稿点评:
提交
down
wechat
bug